These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
238 related items for PubMed ID: 15063812
1. Association of plasma atrial natriuretic peptide, N-terminal proatrial natriuretic peptide, and brain natriuretic peptide levels with coronary artery stenosis in patients with normal left ventricular systolic function. Nishikimi T, Mori Y, Ishimura K, Tadokoro K, Yagi H, Yabe A, Horinaka S, Matsuoka H. Am J Med; 2004 Apr 15; 116(8):517-23. PubMed ID: 15063812 [Abstract] [Full Text] [Related]
2. Midregional pro-atrial natriuretic peptide is a useful indicator for the detection of impaired left ventricular function in patients with coronary artery disease. Elmas E, Brueckmann M, Lang S, Kälsch T, Haghi D, Sueselbeck T, Dempfle CE, Borggrefe M. Int J Cardiol; 2008 Aug 18; 128(2):244-9. PubMed ID: 17673312 [Abstract] [Full Text] [Related]
3. Natriuretic peptides in patients with aortic stenosis. Qi W, Mathisen P, Kjekshus J, Simonsen S, Bjørnerheim R, Endresen K, Hall C. Am Heart J; 2001 Oct 18; 142(4):725-32. PubMed ID: 11579366 [Abstract] [Full Text] [Related]
4. Risk assessment in patients with unstable angina/non-ST-elevation myocardial infarction and normal N-terminal pro-brain natriuretic peptide levels by N-terminal pro-atrial natriuretic peptide. Jarai R, Iordanova N, Jarai R, Raffetseder A, Woloszczuk W, Gyöngyösi M, Geyer G, Wojta J, Huber K. Eur Heart J; 2005 Feb 18; 26(3):250-6. PubMed ID: 15618049 [Abstract] [Full Text] [Related]
5. N-terminal proatrial natriuretic peptide and prognosis in patients with heart failure and preserved systolic function. Andersson B, Hall C. J Card Fail; 2000 Sep 18; 6(3):208-13. PubMed ID: 10997746 [Abstract] [Full Text] [Related]
6. [Relationship between brain natriuretic peptide and coronary stenosis: influence of aging]. Suzuki N, Mori H, Hazama M, Takahashi K, Moriya M, Yano K. J Cardiol; 2004 Mar 18; 43(3):117-22. PubMed ID: 15067799 [Abstract] [Full Text] [Related]
7. Comparison of midregional pro-atrial and B-type natriuretic peptides in chronic heart failure: influencing factors, detection of left ventricular systolic dysfunction, and prediction of death. Moertl D, Berger R, Struck J, Gleiss A, Hammer A, Morgenthaler NG, Bergmann A, Huelsmann M, Pacher R. J Am Coll Cardiol; 2009 May 12; 53(19):1783-90. PubMed ID: 19422985 [Abstract] [Full Text] [Related]
8. Usefulness of serum N-terminal pro-brain natriuretic peptide to predict in-stent restenosis in patients with preserved left ventricular function and normal troponin I levels. Hong SN, Ahn Y, Yoon NS, Lee KH, Kim YS, Hwang SH, Lee SR, Kim KH, Park HW, Hong YJ, Kim JH, Jeong MH, Cho JG, Park JC, Kang JC. Am J Cardiol; 2007 Apr 15; 99(8):1051-4. PubMed ID: 17437726 [Abstract] [Full Text] [Related]
9. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure. von Haehling S, Jankowska EA, Morgenthaler NG, Vassanelli C, Zanolla L, Rozentryt P, Filippatos GS, Doehner W, Koehler F, Papassotiriou J, Kremastinos DT, Banasiak W, Struck J, Ponikowski P, Bergmann A, Anker SD. J Am Coll Cardiol; 2007 Nov 13; 50(20):1973-80. PubMed ID: 17996563 [Abstract] [Full Text] [Related]
10. Effects of exercise testing on natriuretic peptide secretion in patients with atrial fibrillation. Wozakowska-Kapłon B, Opolski G. Kardiol Pol; 2009 Mar 13; 67(3):254-61. PubMed ID: 19378231 [Abstract] [Full Text] [Related]
11. [Clinical significance of plasma atrial and brain natriuretic peptide levels during hemodialysis in hemodialysis patients with old myocardial infarction]. Uetake S, Takahashi M, Tamano K, Honda T, Kobayashi T, Horinaka S. J Cardiol; 2001 Aug 13; 38(2):61-71. PubMed ID: 11525111 [Abstract] [Full Text] [Related]
12. N-terminal pro-atrial natriuretic peptide (N-ANP) and N-terminal pro-B-type natriuretic peptide (N-BNP) in the prediction of death and heart failure in unselected patients following acute myocardial infarction. Squire IB, O'Brien RJ, Demme B, Davies JE, Ng LL. Clin Sci (Lond); 2004 Sep 13; 107(3):309-16. PubMed ID: 15182235 [Abstract] [Full Text] [Related]
13. Right heart overload contributes to cardiac natriuretic hormone elevation in patients with heart failure. Passino C, Maria Sironi A, Favilli B, Poletti R, Prontera C, Ripoli A, Lombardi M, Emdin M. Int J Cardiol; 2005 Sep 15; 104(1):39-45. PubMed ID: 16137508 [Abstract] [Full Text] [Related]
14. Reduced levels of N-terminal-proatrial natriuretic peptide in hypertensive patients with metabolic syndrome and their relationship with left ventricular mass. Rubattu S, Sciarretta S, Ciavarella GM, Venturelli V, De Paolis P, Tocci G, De Biase L, Ferrucci A, Volpe M. J Hypertens; 2007 Apr 15; 25(4):833-9. PubMed ID: 17351376 [Abstract] [Full Text] [Related]
15. Influence of left ventricular filling pattern on exercise-induced changes of natriuretic peptides in patients with suspected coronary artery disease. Møller JE, Bergeron S, Jaffe A, Pellikka PA. Int J Cardiol; 2008 Feb 29; 124(2):204-10. PubMed ID: 17442418 [Abstract] [Full Text] [Related]
16. Presence and severity of coronary artery disease and changes in B-type natriuretic peptide levels in patients with a normal systolic function. Kim BS, Lee HJ, Shin HS, Yoon JH, Lee HY, Kim BJ, Sung KC, Kang JH, Lee MH, Park JR. Transl Res; 2006 Oct 29; 148(4):188-95. PubMed ID: 17002921 [Abstract] [Full Text] [Related]